SK9042001A3 - The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life - Google Patents

The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life Download PDF

Info

Publication number
SK9042001A3
SK9042001A3 SK904-2001A SK9042001A SK9042001A3 SK 9042001 A3 SK9042001 A3 SK 9042001A3 SK 9042001 A SK9042001 A SK 9042001A SK 9042001 A3 SK9042001 A3 SK 9042001A3
Authority
SK
Slovakia
Prior art keywords
utilisation
medicament
inhibitors
producing
sodium hydrogen
Prior art date
Application number
SK904-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Wolfgang Linz
Hans Jochen Lang
Bela Kelety
Peter Schmid
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of SK9042001A3 publication Critical patent/SK9042001A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
SK904-2001A 1998-12-23 1999-12-08 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life SK9042001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859727A DE19859727A1 (de) 1998-12-23 1998-12-23 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
PCT/EP1999/009621 WO2000038661A2 (de) 1998-12-23 1999-12-08 Die verwendung von hemmern des natrium-wasserstoff-austauschers zur herstellung eines medikaments zur verhinderung von altersbedingten organ-dysfunktionen, altersbedingten erkrankungen und zur lebensverlängerung

Publications (1)

Publication Number Publication Date
SK9042001A3 true SK9042001A3 (en) 2001-12-03

Family

ID=7892436

Family Applications (1)

Application Number Title Priority Date Filing Date
SK904-2001A SK9042001A3 (en) 1998-12-23 1999-12-08 The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life

Country Status (20)

Country Link
US (1) US6420430B1 (de)
EP (1) EP1140056A2 (de)
JP (1) JP2002533386A (de)
KR (1) KR20010086152A (de)
CN (1) CN1367689A (de)
AR (1) AR021965A1 (de)
AU (1) AU776761B2 (de)
BR (1) BR9916505A (de)
CA (1) CA2357837A1 (de)
CZ (1) CZ20012309A3 (de)
DE (1) DE19859727A1 (de)
HR (1) HRPK20010470B1 (de)
HU (1) HUP0104652A3 (de)
IL (1) IL143372A0 (de)
NO (1) NO20013145L (de)
RU (1) RU2238721C2 (de)
SK (1) SK9042001A3 (de)
TR (1) TR200101803T2 (de)
WO (1) WO2000038661A2 (de)
ZA (1) ZA200104301B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
KR20040083498A (ko) * 2002-02-04 2004-10-02 아벤티스 파마 도이칠란트 게엠베하 심부전증 및 기타 노화-관련된 기관의 기능장애,노화-관련 질환을 예방하고 생명을 연장하기 위한 ａｃｅ억제제와 나트륨-수소 교환 억제제 카리포리드와의 배합제제
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
EP1646371A4 (de) * 2003-06-26 2010-09-22 Biotron Ltd Antivirale verbindungen und verfahren
US8013240B2 (en) * 2005-11-02 2011-09-06 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US7947897B2 (en) * 2005-11-02 2011-05-24 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US8017863B2 (en) * 2005-11-02 2011-09-13 The Regents Of The University Of Michigan Polymer wrapped carbon nanotube near-infrared photoactive devices
KR101042078B1 (ko) * 2009-01-13 2011-06-16 한국항공우주산업 주식회사 치공구 제작용 수평 측면 가공 치구
CN104103253B (zh) 2014-07-04 2016-08-17 京东方科技集团股份有限公司 发射电极扫描电路、阵列基板和显示装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE147375T1 (de) 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
DK0590455T3 (da) * 1992-09-28 2001-01-22 Hoechst Ag Antiarrytmiske og cardioprotektive substiuerede 1(2H)-isoquinoliner, fremgangsmåde til deres fremstilling, lægemiddel indeh
SE508028C2 (sv) * 1993-05-12 1998-08-10 Moelnlycke Ab Midjebälte för absorberande plagg
DE4328352A1 (de) 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5506065A (en) 1994-02-25 1996-04-09 Whitehead Alenia Sistemi Subacquei S.P.A. Electrolyte-activated battery
DE4430861A1 (de) 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19502644A1 (de) 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
ATE183498T1 (de) * 1995-04-18 1999-09-15 Hoechst Ag Substituierte indenoylguanidines mit antiarrhythmischer und cardioprotektiver wirkung
EP0765867A1 (de) 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19622222A1 (de) * 1996-06-03 1997-12-04 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
JP2002502414A (ja) * 1997-06-02 2002-01-22 藤沢薬品工業株式会社 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
CA2260499A1 (en) * 1998-01-29 1999-07-29 Sumitomo Pharmaceuticals Company Limited Pharmaceutical compositions for the treatment of ischemic brain damage

Also Published As

Publication number Publication date
DE19859727A1 (de) 2000-06-29
HRP20010470A2 (en) 2002-06-30
TR200101803T2 (tr) 2001-10-22
AU776761B2 (en) 2004-09-23
WO2000038661A2 (de) 2000-07-06
NO20013145D0 (no) 2001-06-22
JP2002533386A (ja) 2002-10-08
CA2357837A1 (en) 2000-07-06
IL143372A0 (en) 2002-04-21
US6420430B1 (en) 2002-07-16
RU2238721C2 (ru) 2004-10-27
AU1657600A (en) 2000-07-31
WO2000038661A3 (de) 2000-11-09
HUP0104652A3 (en) 2002-09-30
RU2001120358A (ru) 2005-12-10
NO20013145L (no) 2001-08-22
HRPK20010470B1 (en) 2003-10-31
CZ20012309A3 (cs) 2001-09-12
EP1140056A2 (de) 2001-10-10
ZA200104301B (en) 2003-02-20
KR20010086152A (ko) 2001-09-08
HUP0104652A2 (hu) 2002-03-28
BR9916505A (pt) 2001-11-20
AR021965A1 (es) 2002-09-04
CN1367689A (zh) 2002-09-04

Similar Documents

Publication Publication Date Title
DZ2744A1 (fr) Distribution d'un agent actif aérosolé.
SK9042001A3 (en) The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life
CO5160257A1 (es) La n-piperidino-5-(4-bromofenil)-1-(2,4-diclorofenil)-4-etilpirazol-3-carboxamida, sus sales, su preparacion y las composiciones farmaceuticas que la contienen
IT1307047B1 (it) Apparecchiatura per il trattamento umidificato dell'apnea da sonno.
SE9504661D0 (sv) New compounds
DE69935108D1 (de) Gekühltes Turbinengehäuse
DE19882794T1 (de) Wasserstoffspeicherzusammensetzung
ATE289509T1 (de) Acyl guanidin natrium/protonen-austauschhemmer
DE69819306D1 (de) Flüssigkeitsundurchlässige Gesichtsmaske
HUP9801924A3 (en) Combination containing sodium/hydrogen exchange inhibitors
ITRM970254A0 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
FR2796829B1 (fr) Plaque d'osteotomie tibiale
DE69801679D1 (de) Gesichertes speicherverwaltungsverfahren
IL131002A0 (en) An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors
BR0110268A (pt) Inibidores de permutadores sódio-hidrogênio do tipo 1(nhe-1)
DZ3463A1 (fr) Cristaux d'inhibiteurs de l'echangeur sodium-hydrogene de type 1
FI980867A0 (fi) Laakerielin
ID27943A (id) Pelat untuk peralatan pengkawatan
DE29702012U1 (de) Wechselkursrechner
DE1025575T1 (de) Kaltkathode kohlerstoff-film
KR960019834U (ko) 일회용 사물보관함(disposable storage box for personal thing property)
FR2722986B1 (fr) Utilisation d'un inhibiteur de la no-synthetase comme medicament destine a reduire la consommation d'alcool ou prevenir l'exces de consommation d'alcool
KR980000545U (ko) 생활 정보지 종합 꽂이함
DE9400831U1 (de) Harnröhrenverschluß (HV)
DE59604427D1 (de) Speicherverwaltungsverfahren